19 Hrs
Source:
سواليف
Source: سواليف
19 Hrsسواليف
Source: سواليف
19 HrsReady to play
Ready to play
A phase II clinical trial involving 109 people with blood disorders that can precede leukemia found, in an exploratory analysis, that taking 1,000 milligrams of vitamin C daily was associated with a 65% lower risk of death over three years of follow-up. However, the reduction in progression to high-risk disorders was not statistically significant, so the findings do not prove that the vitamin prevents cancer or extends life. The researchers called for a larger trial to confirm the potential benefit, stressing that high doses are not a proven means of prevention or a substitute for medical monitoring.
Notice: This Is an AI-Generated Summary
Comments (0)